Sinopharm Group Ltd Stock Today
| SHTDY Stock | USD 12.80 0.35 2.66% |
Performance6 of 100
| Odds Of DistressLess than 10
|
SINOPHARM GROUP is trading at 12.80 as of the 25th of November 2024; that is 2.66% down since the beginning of the trading day. The stock's open price was 13.15. SINOPHARM GROUP has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for SINOPHARM GROUP LTD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Sinopharm is traded on OTC Exchange in the United States.. The company has 624.13 M outstanding shares. More on SINOPHARM GROUP LTD
Moving together with SINOPHARM Pink Sheet
Moving against SINOPHARM Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
SINOPHARM Pink Sheet Highlights
| President | Yong Liu |
| Business Concentration | Medical Distribution, Healthcare (View all Sectors) |
SINOPHARM GROUP LTD [SHTDY] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.61 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SINOPHARM GROUP's market, we take the total number of its shares issued and multiply it by SINOPHARM GROUP's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. SINOPHARM GROUP LTD classifies itself under Healthcare sector and is part of Medical Distribution industry. The entity has 624.13 M outstanding shares.
SINOPHARM GROUP LTD has accumulated about 38.21 B in cash with 9.31 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 61.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check SINOPHARM GROUP Probability Of Bankruptcy
Ownership AllocationSINOPHARM GROUP LTD shows a total of 624.13 Million outstanding shares. About 99.99 % of SINOPHARM GROUP outstanding shares are held by general public with 0.01 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check SINOPHARM Ownership Details
SINOPHARM GROUP LTD Risk Profiles
| Mean Deviation | 2.08 | |||
| Semi Deviation | 2.82 | |||
| Standard Deviation | 2.83 | |||
| Variance | 8.01 |
SINOPHARM Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in SINOPHARM GROUP without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Additional Tools for SINOPHARM Pink Sheet Analysis
When running SINOPHARM GROUP's price analysis, check to measure SINOPHARM GROUP's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SINOPHARM GROUP is operating at the current time. Most of SINOPHARM GROUP's value examination focuses on studying past and present price action to predict the probability of SINOPHARM GROUP's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SINOPHARM GROUP's price. Additionally, you may evaluate how the addition of SINOPHARM GROUP to your portfolios can decrease your overall portfolio volatility.